| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (synonymous variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E +1 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E +2 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (intron variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Duplication (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Microsatellite (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +2 more | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E +3 more | |
| | | Single nucleotide variant (nonsense) | Autosomal recessive limb-girdle muscular dystrophy type 2E +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Qualitative or quantitative defects of beta-sarcoglycan +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Limb-girdle muscular dystrophy, recessive +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Primary dilated cardiomyopathy +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +3 more | GPathogenic/Likely pathogenic |